Viral-associated lymphoid proliferations
- PMID: 23537914
- PMCID: PMC3686967
- DOI: 10.1053/j.semdp.2012.08.009
Viral-associated lymphoid proliferations
Abstract
The histological spectrum of viral-associated lymphoid proliferations is quite broad, ranging from reactive lymphadenitis to atypical proliferations mimicking classical Hodgkin lymphoma or non-Hodgkin lymphoma. Virally associated reactive lesions can appear quite alarming on histological examination, because of direct (cytopathic) and indirect viral-induced changes eliciting a polymorphic cellular host response. In addition, the atypical lymphoid proliferation may show aberrant phenotypic features as well as restricted/clonal gene immunoglobulin or T-cell receptor rearrangements, further complicating the interpretation. In order to achieve an accurate diagnosis, it is important to be aware of the clinical history, including family history and ethnic background, clinical presentation, symptoms, and extent of the disease. Among the clinical data, particular emphasis should be placed on serology and viral load studies, and the use of immunosuppressive drugs. The clinical course and outcome vary greatly, from an indolent, self-limited to aggressive clinical course, blurring at times the distinction between neoplastic and reactive proliferations. It is now recognized that immunosenescence also plays a significant role in the development of these viral-associated lymphoid proliferations, and new entities have been described in recent years. In this review we discuss mostly Epstein-Barr virus-associated viral proliferations that may be confused with lymphomas, which the practicing pathologist may encounter.
Published by Elsevier Inc.
Figures



Similar articles
-
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.Mod Pathol. 2017 May;30(5):745-760. doi: 10.1038/modpathol.2016.233. Epub 2017 Jan 13. Mod Pathol. 2017. PMID: 28084335
-
Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update.Hum Pathol. 2018 Sep;79:18-41. doi: 10.1016/j.humpath.2018.05.020. Epub 2018 Jun 6. Hum Pathol. 2018. PMID: 29885408 Review.
-
Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.Hum Pathol. 2010 Dec;41(12):1802-8. doi: 10.1016/j.humpath.2010.04.019. Epub 2010 Sep 24. Hum Pathol. 2010. PMID: 20869749
-
Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.Pediatr Dev Pathol. 2008 Nov-Dec;11(6):443-9. doi: 10.2350/07-12-0386.1. Pediatr Dev Pathol. 2008. PMID: 18473605
-
New developments in non-Hodgkin lymphoid malignancies.Pathology. 2021 Apr;53(3):349-366. doi: 10.1016/j.pathol.2021.01.002. Epub 2021 Mar 5. Pathology. 2021. PMID: 33685720 Review.
Cited by
-
Non-neoplastic B-cell predominant lymphoid proliferations at the organs exposed to external environment mimicking lymphoma: A potential diagnostic pitfall.Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241264369. doi: 10.1177/03946320241264369. Int J Immunopathol Pharmacol. 2024. PMID: 38886178 Free PMC article.
-
Characteristic Histological Findings of Asymptomatic EBV-associated Lymphoproliferative Disorders in Tonsils.J Clin Exp Hematop. 2018 Sep 19;58(3):122-127. doi: 10.3960/jslrt.18017. Epub 2018 Jul 14. J Clin Exp Hematop. 2018. PMID: 30012922 Free PMC article.
-
Early lymphoid lesions: conceptual, diagnostic and clinical challenges.Haematologica. 2014 Sep;99(9):1421-32. doi: 10.3324/haematol.2014.107938. Haematologica. 2014. PMID: 25176983 Free PMC article. Review.
-
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.Exp Mol Med. 2015 Jan 23;47(1):e133. doi: 10.1038/emm.2014.105. Exp Mol Med. 2015. PMID: 25613730 Free PMC article. Review.
References
-
- Cohen JI. Epstein–Barr virus infection. N Engl J Med. 2000;343(7):481–492. - PubMed
-
- Rickinson AB, Kieff E. Epstein–Barr Virus. 5. Philadelphia: Lippincott Williams & Wilkins; 2007.
-
- Thorley-Lawson DA. Epstein–Barr virus: exploiting the immune system. Nat Rev Immunol. 2001;1(1):75–82. - PubMed
-
- Kalla M, Hammerschmidt W. Human B cells on their route to latent infection—early but transient expression of lytic genes of Epstein–Barr virus. Eur J Cell Biol. 2011 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical